These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 10743055)
1. [Interleukin-6 functions as an autocrine growth stimulator for a human lung adenocarcinoma cell line PAa]. Fu J; Fang W; Zheng J Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):45-8. PubMed ID: 10743055 [TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-6 on the growth of human lung cancer cell line. Fu J; Zheng J; Fang W; Wu B Chin Med J (Engl); 1998 Mar; 111(3):265-8. PubMed ID: 10374431 [TBL] [Abstract][Full Text] [Related]
3. [Interleukin-6 behaves as an autocrine growth stimulator for a human lung giant cell carcinoma cell line]. Fu J; Zheng J; Fang W Zhonghua Bing Li Xue Za Zhi; 1997 Feb; 26(1):5-7. PubMed ID: 10072840 [TBL] [Abstract][Full Text] [Related]
4. [Growth regulatory mechanisms of recombinant human interleukin-6 on human lung carcinoma cell lines]. Fu J; Wu B; Zheng J Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):194-6. PubMed ID: 9596958 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Takizawa H; Ohtoshi T; Ohta K; Yamashita N; Hirohata S; Hirai K; Hiramatsu K; Ito K Cancer Res; 1993 Sep; 53(18):4175-81. PubMed ID: 8364912 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Zhu YM; Webster SJ; Flower D; Woll PJ Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974 [TBL] [Abstract][Full Text] [Related]
7. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282 [TBL] [Abstract][Full Text] [Related]
8. IL-6 antisense-mediated growth inhibition of a choriocarcinoma cell line: an intracellular autocrine growth mechanism. Kong B; Isozaki T; Sasaki S Gynecol Oncol; 1996 Oct; 63(1):78-84. PubMed ID: 8898173 [TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of cisplatin resistance by cytokines. Poppenborg H; Knüpfer MM; Galla HJ; Wolff JE Cytokine; 1999 Sep; 11(9):689-95. PubMed ID: 10479405 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 production by human melanoma cell lines. Lee JD; Sievers TM; Skotzko M; Chandler CF; Morton DL; McBride WH; Economou JS Lymphokine Cytokine Res; 1992 Jun; 11(3):161-6. PubMed ID: 1391235 [TBL] [Abstract][Full Text] [Related]
11. [Studies on the interaction between interleukin-6 and human renal cell carcinoma cell line GRC-1]. Xi Z; Yu L; Guo Y Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):308-11. PubMed ID: 11798778 [TBL] [Abstract][Full Text] [Related]
12. Expression of mRNAs for interleukin-4, interleukin-6 and their receptors in porcine corpus luteum during the estrous cycle. Sakumoto R; Komatsu T; Kasuya E; Saito T; Okuda K Domest Anim Endocrinol; 2006 Oct; 31(3):246-57. PubMed ID: 16332426 [TBL] [Abstract][Full Text] [Related]
13. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction. Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038 [TBL] [Abstract][Full Text] [Related]
14. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA. Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 inhibits radiation induced apoptosis in pancreatic cancer cells. Miyamoto Y; Hosotani R; Doi R; Wada M; Ida J; Tsuji S; Kawaguchi M; Nakajima S; Kobayashi H; Masui T; Imamura M Anticancer Res; 2001; 21(4A):2449-56. PubMed ID: 11724306 [TBL] [Abstract][Full Text] [Related]
16. Expression and production of interleukin 10 in human myeloma cell lines. Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145 [TBL] [Abstract][Full Text] [Related]
17. Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells. Keller ET; Ershler WB J Immunol; 1995 Apr; 154(8):4091-8. PubMed ID: 7706747 [TBL] [Abstract][Full Text] [Related]
18. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy. Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641 [TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839 [TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]